[Systemic lupus erythematosus: from adolescence to adulthood].
Mathian
A
A
Service de Médecine Interne 2, Centre de Référence National Pour les Lupus et le Syndrome des Antiphospholipides, CHU Pitié-Salpêtrière, AP-HP, Paris, France. alexis.mathian@psl.aphp.fr
Amoura
Z
Z
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D003131:Combined Modality Therapy; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D010348:Patient Care Team; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy; D015996:Survival Rate / Q000639:trends; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D003278:Contraceptives, Oral, Hormonal; D007166:Immunosuppressive Agents